CME director granted 645 shares in equity award

Maloney Patrick W reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Maloney Patrick W reported acquisition or exercise transactions in this Form 4 filing.

CME Group Inc. director Patrick W. Maloney received a grant of 645 fully vested shares of Class A common stock at $225 per share. The award was issued as part of the company’s annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. Following this grant, Maloney directly holds 4,743 shares of Class A common stock.

Insider Trade Summary

Grant/Award: 645 shares

Grant/Award 1 txn

Insider Maloney Patrick W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Class A	645	$225.00	$145K

Holdings After Transaction: Common Stock Class A — 4,743 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

Key Figures

Shares granted: 645 shares Grant price per share: $225 per share Shares held after grant: 4,743 shares

3 metrics

Shares granted 645 shares Fully vested Class A common stock grant to director

Grant price per share $225 per share Class A common stock equity award

Shares held after grant 4,743 shares Patrick W. Maloney direct Class A holdings post-transaction

Key Terms

annual equity compensation program, CME Group Director Stock Plan, fully vested shares

3 terms

annual equity compensation program financial

"issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors"

CME Group Director Stock Plan financial

"for non-employee directors under the CME Group Director Stock Plan"

fully vested shares financial

"Represents a grant of fully vested shares of Class A Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CME (CME) director Patrick W. Maloney report on this Form 4?

Patrick W. Maloney reported receiving 645 shares of CME Group Class A common stock. The shares were granted at $225 per share as part of the annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.

Was the CME (CME) stock grant to Patrick W. Maloney an open-market purchase?

No, the 645 CME Group shares were a grant, not an open-market purchase. They were issued as part of the company’s annual equity compensation program for non-employee directors, rather than acquired through buying shares in the market.

Are the 645 CME (CME) shares granted to Patrick W. Maloney subject to vesting?

No, the 645 shares are fully vested at grant. The footnote states they were issued as part of CME Group’s annual equity compensation program for non-employee directors and that these Class A common shares are not subject to any vesting conditions.

How many CME (CME) shares does Patrick W. Maloney hold after this transaction?

After the grant, Patrick W. Maloney directly holds 4,743 shares of CME Group Class A common stock. This total includes the newly granted 645 fully vested shares reported in the Form 4 insider transaction filing.

What plan governed the CME (CME) share grant to Patrick W. Maloney?

The grant was made under the CME Group Director Stock Plan. According to the footnote, it represents fully vested Class A common shares issued as part of the issuer’s annual equity compensation program for non-employee directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:21 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maloney Patrick W

(Last) (First) (Middle)

20 S. WACKER DR.

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock Class A	06/25/2026		A(1)		645	A	$225	4,743	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.

Remarks:

	/s/ Elizabeth Hensen, as Attorney-in-Fact for Patrick W. Maloney	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)